20+ years of transaction experience across the DACH region and Europe
Specializes in technology and technology-enabled services
Expertise in B2B, vertical software as a service and digital platforms
Munich
@alvarezmarsal
LinkedIn
Copied!
Christian Ramme is a Managing Director with Alvarez & Marsal Corporate Finance in Munich. He specializes in mid-market transactions in the technology and technology-enabled services sector in Germany, Austria, and Switzerland (the DACH region). He leverages A&M’s global network of entrepreneurs, high-growth technology companies, major international corporations, and leading private equity investors to create valuable connections for the firm’s clients.
Mr. Ramme brings over 20 years of experience in cross-border M&A, direct investment, and growth equity. For more than 15 years, his focus has been on German and European B2C and B2B technology companies.
Prior to joining A&M, Mr. Ramme served as Investment Lead and Head of DACH at Tenzing, a growth private equity investor specializing in technology and technology-enabled businesses in the U.K. and Europe. Previously, Mr. Ramme was Managing Partner and Co-Head of M&A for the technology, media, and telecommunications sector at KPMG in Germany. Before that, he was Head of Growth Capital and Managing Director of the Technology practice at the Frankfurt-based European investment banking boutique ACXIT Capital Partners.
Mr. Ramme earned a master’s degree in economics from Maastricht University. He is involved as a mentor at the tech startup accelerator TechFounders, an initiative by UnternehmerTUM, and most notably served as a board member at Mahr EDV, a leading managed-IT services provider in Germany.
The new Managing Director in Munich brings more than two decades’ experience in the technology sector to help meet growing client demand for M&A and investment advisory. The senior appointment builds on the recent launch of the fast-growing practice in Germany.
Latest insightsThe latest insights from Christian Ramme's team
The medical consumables sector is a vital component of healthcare, underpinning diagnostics, treatment, and infection prevention. With a global market projected to grow from $422 billion in 2025 to $571 billion by 2035, at a CAGR of 3.2%, the sector is poised for steady expansion.
